EXHIBIT 10.20

 

COMPENSATION INFORMATION FOR NAMED EXECUTIVE OFFICERS

 

The table below provides information regarding the 2009 annual base salary and
target percentage for a cash incentive payment for performance in 2009, of each
named executive officer of ARYx Therapeutics, Inc.

 

 

 

 

 

2009 Target Cash

 

 

 

 

 

Incentive Payment

 

 

 

 

 

(As%

 

 

 

2009 Annual Base

 

of 2009 Annual

 

Name and Principal Position

 

Salary

 

Base Salary)

 

Paul Goddard, Ph.D.

 

 

 

 

 

Chairman and Chief Executive Officer

 

$

451,000

 

75.0

%

Peter G. Milner, M.D.

 

 

 

 

 

President, Research and Development

 

$

333,000

 

52.5

%

John Varian

 

 

 

 

 

Chief Operating Officer and Chief Financial Officer

 

$

324,000

 

52.5

%

Pascal Druzgala, Ph.D.

 

 

 

 

 

Vice President and Chief Scientific Officer

 

$

283,000

 

45.0

%

Daniel Canafax, Pharm.D.

 

 

 

 

 

Vice President and Chief Development Officer

 

$

270,000

 

45.0

%

David Nagler

 

 

 

 

 

Vice President, Corporate Affairs and Secretary

 

$

256,000

 

45.0

%

 

--------------------------------------------------------------------------------